I was merely bringing up what Dr. Urano had said. Is that inappropriate here? I don't ever recall "belly aching" about the "small molecule" method, just wondering if our MANF patent was restricted to healing the eye damaged by wolframs, or whether Urano was still on target to use our patent to cure wolframs itself. I think that is an important distinction, because being a part of the cure for wolframs would be part of the cure for diabetes!
I guess on this mb raising a question about a possible disappointment is tantamount to "belly aching?"
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links